Anna H. Huppler, MD

Publications

• Chemokine CCL28 Is a Potent Therapeutic Agent for Oropharyngeal Candidiasis.

  (He J, Thomas MA, de Anda J, Lee MW, Van Why E, Simpson P, Wong GCL, Grayson MH, Volkman BF, Huppler AR.) Antimicrob Agents Chemother. 2020 07 22;64(8) PMID: 32423961 PMCID: PMC7526824 SCOPUS ID: 2-s2.0-85088608725 05/20/2020

• Erratum to: Attenuation of Helper T Cell Capacity for TH1 and TH17 Differentiation in Children With Nontuberculous Mycobacterial Infection.

  (Claeys TA, Rosas Mejia O, Marshall S, Jarzembowski JA, Hayes D, Hull NM, Liyanage NPM, Chun RH, Sulman CG, Huppler AR, Robinson RT.) J Infect Dis. 2020 05 11;221(11):1917 PMID: 31904837 SCOPUS ID: 2-s2.0-85084695497 01/07/2020

• Switchable Membrane Remodeling and Antifungal Defense by Metamorphic Chemokine XCL1.

  (Dishman AF, Lee MW, de Anda J, Lee EY, He J, Huppler AR, Wong GCL, Volkman BF.) ACS Infect Dis. 2020 05 08;6(5):1204-1213 PMID: 32243126 PMCID: PMC7258946 SCOPUS ID: 2-s2.0-85084720920 04/04/2020

• The Interleukin (IL) 17R/IL-22R Signaling Axis Is Dispensable for Vulvovaginal Candidiasis Regardless of Estrogen Status.

  (Peters BM, Coleman BM, Willems HME, Barker KS, Aggor FEY, Cipolla E, Verma AH, Bishu S, Huppler AH, Bruno VM, Gaffen SL.) J Infect Dis. 2020 04 07;221(9):1554-1563 PMID: 31805183 PMCID: PMC7137889 SCOPUS ID: 2-s2.0-85078761600 12/06/2019

• Attenuation of Helper T Cell Capacity for TH1 and TH17 Differentiation in Children With Nontuberculous Mycobacterial Infection.

  (Claeys TA, Rosas Mejia O, Marshall S, Jarzembowski JA, Hayes D Jr, Hull NM, Liyanage NPM, Chun RH, Sulman CG, Huppler AR, Robinson RT.) J Infect Dis. 2019 10 22;220(11):1843-1847 PMID: 31332447 PMCID: PMC7325325 SCOPUS ID: 2-s2.0-85073665266 07/25/2019

• Pediatric Deep Neck Space Infections: A Medical and Surgical Perspective

  (Mohandas S, Gregory S, Chun RH, Huppler AR.) Journal of Pediatric Infectious Diseases. 2019;14(2):43-51 SCOPUS ID: 2-s2.0-85049857631 01/01/2019

• Successful Treatment of Invasive Conidiobolus Infection During Therapy for Acute Lymphoblastic Leukemia.

  (Erker C, Huppler AR, Walsh TJ, McCormick ME, Suchi M, Bhatt NS, Kehl SC, Southwood J, Harker-Murray P.) J Pediatr Hematol Oncol. 2018 10;40(7):e446-e449 PMID: 28991126 PMCID: PMC5904005 SCOPUS ID: 2-s2.0-85031495362 10/11/2017

• The Solution Structure of CCL28 Reveals Structural Lability that Does Not Constrain Antifungal Activity.

  (Thomas MA, He J, Peterson FC, Huppler AR, Volkman BF.) J Mol Biol. 2018 09 14;430(18 Pt B):3266-3282 PMID: 29913161 PMCID: PMC6103841 SCOPUS ID: 2-s2.0-85049041059 06/19/2018

• Development and implementation of an antimicrobial lock therapy guideline in a pediatric hospital.

  (Zembles TN, Flannery LS, Huppler AR.) Am J Health Syst Pharm. 2018 03 01;75(5):299-303 PMID: 29472511 SCOPUS ID: 2-s2.0-85042408173 02/24/2018

• Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin.

  (Verma AH, Richardson JP, Zhou C, Coleman BM, Moyes DL, Ho J, Huppler AR, Ramani K, McGeachy MJ, Mufazalov IA, Waisman A, Kane LP, Biswas PS, Hube B, Naglik JR, Gaffen SL.) Sci Immunol. 2017 11 03;2(17) PMID: 29101209 PMCID: PMC5881387 SCOPUS ID: 2-s2.0-85034226532 11/05/2017

• Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children.

  (Huppler AR, Fisher BT, Lehrnbecher T, Walsh TJ, Steinbach WJ.) J Pediatric Infect Dis Soc. 2017 Sep 01;6(suppl_1):S32-S44 PMID: 28927202 PMCID: PMC5907877 SCOPUS ID: 2-s2.0-85045043737 09/21/2017

• The Goldilocks model of immune symbiosis with Mycobacteria and Candida colonizers.

  (Robinson RT, Huppler AR.) Cytokine. 2017 09;97:49-65 PMID: 28570933 PMCID: PMC5765749 SCOPUS ID: 2-s2.0-85019740661 06/02/2017